Literature DB >> 11033126

Effect of decreased retinal illumination on frequency doubling technology.

S Kogure1, W L Membrey, F W Fitzke, S Tsukahara.   

Abstract

PURPOSE: To investigate the effect of changes in retinal illumination on Frequency Doubling Technology (FDT).
METHODS: Five eyes, of 5 adults who were free from identifiable ocular pathology, were examined using the Snellen chart and the Pelli-Robson chart, conventional automated perimetry, and the full threshold N-30 program of FDT. Each test was performed with and without a 0.9, 1.5, or 2.4 log unit neutral-density (ND) filter placed before the eye. Furthermore, the influence of pupil diameter on FDT test results was compared after treatment with pilocarpine or cyclopentolate with the influence of ND filters.
RESULTS: All tests showed a decrease in sensitivity with decreasing retinal illumination. Frequency Doubling Technology showed an especially pronounced and significant decrease in sensitivity. The maximum mean threshold difference in FDT results with ND filter was 31.2 dB while that with the Humphrey Field Analyzer and the Pelli-Robson chart were 13.3 dB and 0.66 log contrast, respectively. The mydriatic state of the pupil increased the sensitivity of FDT and the miotic state decreased it to about the same extent as the the 0.9 ND filter.
CONCLUSION: The change in retinal illumination has more impact on FDT than on spatial contrast tests and conventional automated perimetry. It is important to take this into account in evaluating FDT results.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11033126     DOI: 10.1016/s0021-5155(00)00224-0

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  9 in total

1.  Characteristics of the normative database for the Humphrey matrix perimeter.

Authors:  Andrew John Anderson; Chris A Johnson; Murray Fingeret; John L Keltner; Paul G D Spry; Michael Wall; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

2.  The effects of interocular differences in retinal illuminance on vision and binocularity.

Authors:  Yoon-Hee Chang; Jong Bok Lee; Nam Soo Kim; Dong Wook Lee; Jee Ho Chang; Sueng-Han Han
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

3.  Assessing spatial and temporal properties of perimetric stimuli for resistance to clinical variations in retinal illumination.

Authors:  William H Swanson; Mitchell W Dul; Douglas G Horner; Tiffany Liu; Irene Tran
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-20       Impact factor: 4.799

4.  Agreement between frequency doubling perimetry and static perimetry in eyes with high tension glaucoma and normal tension glaucoma.

Authors:  S Kogure; Y Toda; D Crabb; K Kashiwagi; F W Fitzke; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

5.  Prediction of future scotoma on conventional automated static perimetry using frequency doubling technology perimetry.

Authors:  S Kogure; Y Toda; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

6.  Choice of Stimulus Range and Size Can Reduce Test-Retest Variability in Glaucomatous Visual Field Defects.

Authors:  William H Swanson; Douglas G Horner; Mitchell W Dul; Victor E Malinovsky
Journal:  Transl Vis Sci Technol       Date:  2014-09-25       Impact factor: 3.283

7.  Optimizing contrast sensitivity perimetry for clinical use.

Authors:  Mitchell W Dul
Journal:  J Ophthalmic Vis Res       Date:  2013-01

8.  Comparison of head-mounted perimeter (imo®) and Humphrey Field Analyzer.

Authors:  Tairo Kimura; Chota Matsumoto; Hiroki Nomoto
Journal:  Clin Ophthalmol       Date:  2019-03-14

9.  Visual Field Testing with Head-Mounted Perimeter 'imo'.

Authors:  Chota Matsumoto; Sayaka Yamao; Hiroki Nomoto; Sonoko Takada; Sachiko Okuyama; Shinji Kimura; Kenzo Yamanaka; Makoto Aihara; Yoshikazu Shimomura
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.